Later on, by using a monoclonal antibody (ATN-658) raised against human uPAR protein, our group showed the ability of ATN-658 to block prostate cancer cell proliferation, invasion, and metastasis (136). This evidence concerns the gene PLAUR and Familial prostate cancer.